Strategic Differentiation
Leading a New Frontier in Nuclear Medicine
Beyond Half-life, Delivering Life.
Beyond Half-life, Delivering Life.
Racing Every Second, Upholding Standards for 15 Years.
Racing Every Second. High Standards for 15 Years.
01
Strategically Differentiated R&D
R&D Strategy
Strategically Differentiated R&D
Connecting International New Drug Landscapes
Rather than following conventional paths, we proactively identify clinical gaps in precision medicine. Through deep technical ties with global research institutions, we optimize molecular conversion efficiency, focusing on high-barrier, difficult-to-replicate radiopharmaceutical R&D platforms—ranging from preclinical research to commercial production, providing partners with truly differentiated integrated solutions.
02
High-Efficiency Manufacturing System
Advanced Manufacturing
High-Efficiency Manufacturing System
Challenging the Limits of Half-Life Logistics
Radiopharmaceutical activity diminishes by the second, leaving no room for error at any stage. Anchored by a PIC/S GMP-certified facility, we integrate cyclotron production, closed sterile synthesis kits, and a tungsten vial tracking management system. Aiming for 15 years of zero-supply-error operation, we ensure that every dose arriving at the clinical site meets the hospital's precise specifications.
03 — Our Commitment
Quality is Not a Starting Point,
It is the Result We Must Defend Every Day
Every Dose, A Commitment.
Every Dose, A Commitment.
In 2014, we became the first private radiopharmaceutical sterile preparation manufacturer in Asia to pass PIC/S GMP certification, and have since passed TFDA inspections 9 times. This certification is not just a milestone, but a daily operational quality standard—for every patient relying on precise diagnosis, every physician trusting our supply, and every investor evaluating our long-term value, our answer remains unwavering.
15+ YRS
Best Service
7762
Stock Code
NO. 1
Asia Private GMP